Replimune Group, Inc. (REPL) has 117 open-market insider trades by 21 insiders since 2018. Over the last six months insiders net sold $1.5M. The most active filer is Colin Love, COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jason P. Rhodes | Dir | — | 6 | $32.1M | 2021-01-26 |
| Robert Coffin | Dir | — | 14 | $21.4M | 2024-05-16 |
| Colin Love | COO | — | 20 | $13.5M | 2024-05-16 |
| Philip Astley-Sparke | Dir | — | 11 | $7.7M | 2026-08-20 |
| Bain Capital Life Sciences Investors, LLC | Dir10% Owner | — | 1 | $7.5M | 2018-07-24 |
| Pamela Esposito | — | — | 9 | $5.5M | 2023-09-12 |
| Omega Fund IV G.P. Manager, Ltd. | 10% Owner | — | 5 | $5.1M | 2022-03-16 |
| Omega Fund IV GP, L.P. | Dir10% Owner | — | 5 | $4.2M | 2021-11-22 |
| Richard J. Lim | Dir10% Owner | — | 1 | $4.0M | 2018-07-24 |
| Otello Stampacchia | Dir10% Owner | — | 3 | $3.9M | 2021-09-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Emily Luisa Hill | CFO | Sell | $132K | 2026-08-17 |
| Sushil Patel | CEO | Sell | $510K | 2026-08-10 |
| Emily Luisa Hill | CFO | Sell | $148K | 2026-08-10 |
| Konstantinos Xynos | — | Sell | $148K | 2026-08-10 |
| Andrew Schwendenman | CAO | Sell | $99K | 2026-08-10 |
| Christopher Sarchi | CCO | Sell | $111K | 2026-06-01 |
Companies that share insiders with REPL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sushil Patel | CEO | Sell | $190K | 2026-05-18 |
| Emily Luisa Hill | CFO | Sell | $40K | 2026-05-18 |
| Andrew Schwendenman | CAO | Sell | $40K | 2026-05-18 |
| Christopher Sarchi | CCO | Sell | $44K | 2026-05-18 |
| Konstantinos Xynos | — | Sell | $71K | 2026-05-18 |
| Philip Astley-Sparke | Director | Sell | $90K | 2026-05-18 |
| Christopher Sarchi | CCO | Sell | $52K | 2026-04-02 |
| Kapil Dhingra | Director | Sell | $33K | 2025-12-09 |
| Sushil Patel | CEO | Sell | $223K | 2025-12-02 |